A real-time PCR method to genotype mutant mouse models with altered affinity for cardiotonic steroids on the

Peter W Chomczynski1, Kianna M Vires1, Michal Rymaszewski1

  • 1Molecular Research Center, Cincinnati, OH, United States of America.

Plos One
|April 21, 2022
PubMed

Insights

Researchers developed a rapid PCR method to genotype mice with altered Na,K-ATPase affinity for cardiotonic steroids. This advances studies on the Na,K-ATPase receptor and its role in cell signaling and disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The Na,K-ATPase enzyme, specifically its cardiotonic steroid binding site on the α subunit, is crucial for cell signaling and a therapeutic target.
  • Genetically modified mouse models with altered cardiotonic steroid affinity on Na,K-ATPase α1 or α2 isoforms are valuable research tools.
  • Existing genotyping methods for these models can be time-consuming.

Purpose of the Study:

  • To develop a rapid and efficient genotyping method for mouse models with altered Na,K-ATPase affinity.
  • To validate the new method against established techniques and ensure accuracy.
  • To facilitate wider use of these valuable research models.

Main Methods:

  • Development of a real-time PCR assay utilizing specific primers and fluorescent probes for mutant allele detection.
  • Fast-mode PCR processing, enabling up to 15 samples in 40 minutes.
  • Validation through Sanger sequencing and comparison with a previous PCR-gel electrophoresis method.

Main Results:

  • A rapid, real-time PCR method for detecting mutant Na,K-ATPase alleles was successfully developed and validated.
  • The new method demonstrated high efficiency, processing samples significantly faster than previous techniques.
  • Sequence inconsistencies were clarified, and mutations were confirmed in the mouse colony.

Conclusions:

  • The developed genotyping protocol significantly enhances the efficiency of working with Na,K-ATPase mouse models.
  • Improved accessibility to these models and a streamlined genotyping process will accelerate research into Na,K-ATPase function and drug development.
  • This work supports further investigation into the Na,K-ATPase cardiotonic steroid receptor's physiological roles and therapeutic potential.